Richmond, CA, United States of America

Winnie Lui

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Winnie Lui. Retrieved from https://idiyas.com/inventor/winnie-lui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Winnie Lui

Introduction

Winnie Lui is a prominent inventor based in Richmond, CA, known for her significant contributions to the field of nanoparticle delivery systems. With a total of two patents to her name, she has made strides in enhancing therapeutic effects through innovative compositions.

Latest Patents

Winnie Lui's latest patents focus on nanoparticle compositions that comprise combinations of prodrugs of therapeutic agents. These compositions achieve enhanced therapeutic effects compared to those observed when free forms of these therapeutic agents are administered. Her work in this area is paving the way for more effective treatment options.

Career Highlights

Winnie currently works at Celator Pharmaceuticals, Inc., where she applies her expertise in developing advanced drug delivery systems. Her innovative approach has garnered attention in the pharmaceutical industry, contributing to the advancement of therapeutic technologies.

Collaborations

Winnie collaborates with notable colleagues, including Leon Wan and Paul Tardi, who share her commitment to innovation in the pharmaceutical field. Their teamwork fosters an environment of creativity and progress.

Conclusion

Winnie Lui's contributions to nanoparticle delivery systems exemplify her dedication to improving therapeutic outcomes. Her work continues to influence the pharmaceutical industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…